{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:33:55Z","timestamp":1772213635658,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162096"],"award-info":[{"award-number":["PJT-162096"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jacadv.2023.100696","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:14:34Z","timestamp":1699949674000},"page":"100696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Longitudinal Control of Lipid Levels in\u00a0Patients With Premature Coronary\u00a0Artery\u00a0Disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Diana N.","family":"Vikulova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Pinheiro-Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Rojas-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Leblond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon N.","family":"Pimstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-3807","authenticated-orcid":false,"given":"Liam R.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacadv.2023.100696_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2014.04.054","article-title":"Trends in acute myocardial infarction in young patients and differences by sex and race, 2001\u20132010","volume":"64","author":"Gupta","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacadv.2023.100696_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.015293","article-title":"Coronary heart disease mortality declines in the United States from 1979 through 2011 evidence for stagnation in young adults, especially women","volume":"132","author":"Wilmot","year":"2015","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacadv.2023.100696_bib3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacadv.2023.100696_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/JCN.0b013e318292b235","article-title":"Anxiety and adverse health outcomes among cardiac patients: a biobehavioral model","volume":"29","author":"Abed","year":"2014","journal-title":"J\u00a0Cardiovasc Nurs"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100696_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.HCR.0000265036.24157.e7","article-title":"Prevalence of anxiety disorders in men and women with established coronary heart disease","volume":"27","author":"Todaro","year":"2007","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100696_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40695-020-00053-0","article-title":"Contribution of common chronic conditions to midlife physical function decline: the study of women\u2019s health across the Nation","volume":"6","author":"Lange-Maia","year":"2020","journal-title":"Womens Midlife Heal"},{"issue":"9438","key":"10.1016\/j.jacadv.2023.100696_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"9753","key":"10.1016\/j.jacadv.2023.100696_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"9976","key":"10.1016\/j.jacadv.2023.100696_bib9","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jacadv.2023.100696_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.115.019014","article-title":"Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy: 20-year follow-up of west of scotland coronary prevention study","volume":"133","author":"Ford","year":"2016","journal-title":"Circulation"},{"issue":"9808","key":"10.1016\/j.jacadv.2023.100696_bib11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(11)61125-2","article-title":"Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20536 high-risk individuals: a randomised controlled trial","volume":"378","year":"2011","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jacadv.2023.100696_bib12","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehr333","article-title":"The Anglo-Scandinavian cardiac outcomes trial: 11-year mortality follow-up of the lipid-lowering arm in the UK","volume":"32","author":"Sever","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacadv.2023.100696_bib13","first-page":"1263","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Pearson","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100696_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jacadv.2023.100696_bib15","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jacadv.2023.100696_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","article-title":"EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study","volume":"28","author":"Ray","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"8","key":"10.1016\/j.jacadv.2023.100696_bib17","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/2047487320914115","article-title":"Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: a population-level observational cohort study","volume":"28","author":"Harris","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.jacadv.2023.100696_bib18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/2047487318817082","article-title":"Improvement of low-density lipoprotein cholesterol target achievement rates through cardiac rehabilitation for patients after ST elevation myocardial infarction or non-ST elevation myocardial infarction in Germany: results of the PATIENT CARE registry","volume":"26","author":"Schwaab","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacadv.2023.100696_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2017.08.013","article-title":"Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II","volume":"266","author":"Gitt","year":"2017","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.jacadv.2023.100696_bib20","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1177\/2047487318806359","article-title":"Predictors of LDL-cholesterol target value attainment differ in acute and chronic coronary heart disease patients: results from DYSIS II Europe","volume":"25","author":"Ferrieres","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2023.100696_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s12325-020-01285-2","article-title":"Proportion of high-risk\/very high-risk patients in Europe with low-density lipoprotein cholesterol at target according to European guidelines: a systematic review","volume":"37","author":"Bruckert","year":"2020","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.jacadv.2023.100696_bib22","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.numecd.2020.04.030","article-title":"Prevalence of poor lipid control in patients with premature coronary artery disease","volume":"30","author":"Froylan","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100696_bib23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12872-019-1032-4","article-title":"Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real-world prescriptions in Taiwan","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.jacadv.2023.100696_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacadv.2023.100696_bib25","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"20","key":"10.1016\/j.jacadv.2023.100696_bib26","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.jacadv.2023.100696_bib27","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2023.100696_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2020.100036","article-title":"Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: eligibility, utilization, target achievement, and predictors of initiation","volume":"2","author":"Vikulova","year":"2020","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100696_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacadv.2023.100696_bib32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jacl.2016.08.011","article-title":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: frequencies, associations and predictions","volume":"10","author":"Ellis","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"issue":"1","key":"10.1016\/j.jacadv.2023.100696_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"issue":"7\u20138","key":"10.1016\/j.jacadv.2023.100696_bib34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1345\/aph.1H018","article-title":"Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures","volume":"40","author":"Hess","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"22","key":"10.1016\/j.jacadv.2023.100696_bib35","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacadv.2023.100696_bib36","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"25","key":"10.1016\/j.jacadv.2023.100696_bib37","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10349","key":"10.1016\/j.jacadv.2023.100696_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0140-6736(22)00916-3","article-title":"Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial","volume":"400","author":"Kim","year":"2022","journal-title":"Lancet"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23007093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X23007093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:57:34Z","timestamp":1757426254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X23007093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2772963X23007093"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100696","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Control of Lipid Levels in\u00a0Patients With Premature Coronary\u00a0Artery\u00a0Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2023.100696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100696"}}